Asia · News · The Standard

HK-listed Metis TechBio, Eli Lilly strike drug-delivery deal worth up to US$1.1 billion

Published by The Standard · Hong Kong 10 h ago

Hong Kong-listed Metis TechBio (7666) said on Monday it has entered into a collaboration agreement with Eli Lilly worth up to US$1.1 billion to research and develop…

Read the full article on The Standard Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.thestandard.com.hk)

Also worth reading

CNA

Ex-OpenAI employee accused of planting device appears to have Saudi backing, court filing shows

Times of India

T-Pain sues Akon's label over $489,000 in royalties in second lawsuit

South China Morning Post

Is China building a fleet of drone motherships to extend its naval reach?

Yonhap

(LEAD) DaouKiwoom-CJ consortium picked as preferred bidder for debt-laden JoongAng Ilbo

Rappler

Gawilan bags Philippines’ first gold at 2026 Asian Para Games

Asia Times